The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
Forum Comments on Share Price

Related Posts

David Erfle: Cash Position Never Larger, Chaos and...

January 17, 2025

StrategX Provides Update on Critical Metals Exploration Activities...

December 3, 2024

Menzies’ Lady Shenton System Continues to Impress with...

October 29, 2024

Ericsson, Rogers Launch Canada’s First Underground 5G Network...

June 21, 2025

Perpetua Gets US Forest Service Approval for Stibnite...

January 8, 2025

Alvopetro Announces an Operational Update, Q1 2025 Financial...

May 8, 2025

Crypto Market Recap: SEC Issues Crypto ETF Guidance,...

July 8, 2025

Allup Strengthens its Board with Mine and Finance...

August 16, 2024

​Tech 5: NVIDIA Closing in on Apple as...

June 1, 2024

Trump Orders Security Probe on Rare Earths and...

April 23, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,487)
    • Investing (3,803)
    • Politics (5,096)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved